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Abstract
Background: The GABAergic system in the brain seems to be dysfunctional in various psychiatric
disorders. Many studies have suggested so far that, in schizophrenia patients, GABAergic inhibition
is selectively but consistently reduced in the prefrontal cortex (PFC).
Results: This study used a computational model of the PFC to investigate the dynamics of the PFC
circuit with and without chandelier cells and other GABAergic interneurons. The inhibition by
GABAergic interneurons other than chandelier cells effectively regulated the PFC activity with
rather low or modest levels of dopaminergic neurotransmission. This activity of the PFC is
associated with normal cognitive functions and has an inverted-U shaped profile of dopaminergic
modulation. In contrast, the chandelier cell-type inhibition affected only the PFC circuit dynamics
in hyperdopaminergic conditions. Reduction of chandelier cell-type inhibition resulted in bistable
dynamics of the PFC circuit, in which the upper stable state is associated with a hyperactive mode.
When both types of inhibition were reduced, this hyperactive mode and the conventional inverted-
U mode merged.
Conclusion:  The results of our simulation suggest that, in schizophrenia, a reduction of
GABAergic inhibition increases vulnerability to psychosis by (i) producing the hyperactive mode of
the PFC with hyperdopaminergic neurotransmission by dysfunctional chandelier cells and (ii)
increasing the probability of the transition to the hyperactive mode from the conventional inverted-
U mode by dysfunctional GABAergic interneurons.
Background
A number of studies have suggested alterations of the
gamma-aminobutyric acid (GABA) system in the brains of
patients with schizophrenia (for reviews: [1-5]). The alter-
ation of GABAergic neurotransmission in the cortex seems
to be selective for subpopulations of the interneurons [4-
7]. Postmortem studies by Benes and colleagues reported
decreased densities of interneurons in layer II of the pre-
frontal cortex (PFC) and layers II-IV of the cingulate cortex
of patients with schizophrenia [8,9]. Possibly owing to its
compensation, GABAA  receptors were observed to be
upregulated in layers II, III, V and VI in the PFC and layers
II and III in the cingulate cortex [10,11]. Decreased densi-
ties of the interneurons in the PFC and the cingulate cor-
tex might be restricted to the interneurons expressing
calbindin; whether the densities of calretinin (CR)- or par-
valbumin (PV)-interneurons are reduced or not is still
uncertain [6,12-14].
Analyses of postmortem brains of patients with schizo-
phrenia have shown consistent reduction of reelin, PV,
and GAD67, the 67-kilodalton isoform of glutamic acid
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decarboxylase [15-17]. Reelin is secreted preferentially by
cortical GABAergic interneurons in layers I, II and IV and
binds to integrin receptors on dendritic spines of pyrami-
dal neurons or on GABAergic interneurons in layers III-V
expressing the disabled-1 gene product (DAB1) [15,18].
The expression of reelin mRNA was decreased in GABAer-
gic interneurons in layers I, II and IV of schizophrenia
patients [19]. Because reelin plays a role in neuronal
migration and synaptic plasticity in the cerebral cortex
[18,20,21], the reduction of reelin in schizophrenia
would indicate a neurodevelopmental abnormality that
induces a GABAergic deficit in schizophrenia [1,21].
Reduced levels of mRNA for GAD67 in the dorsolateral
prefrontal cortex (DLPFC) of patients with schizophrenia
suggest that GABA synthesis is reduced in schizophrenia
[22-25]. The reduction was detected in about 25-30% of
the GABAergic interneurons in the DLPFC [25,26].
Among many subtypes of GABAergic interneurons in the
cortex, the PV-interneurons contain basket cells and chan-
delier cells, which constitute 20-25% of GABAergic
interneurons in the primate DLPFC [28]. The GABAergic
interneurons that show GAD67 mRNA reduction express
PV [27], suggesting that the reduction is selective. Lewis
and coworkers suggested that the density of the GABA
membrane transporter (GAT1)-immunoreactive axon car-
tridges of chandelier cells was decreased by 40% in schiz-
ophrenic subjects compared to both normal controls and
subjects with other psychotic disorders [29,30]. They
argued that the reduction was due to a decrease in the
number of axon terminals rather than the number of
chandelier cells [29,30]. In contrast, the CR-positive
GABAergic interneurons, which constitute about 50%,
were unaffected [3].
The regulation of GABAergic neurotransmission is critical
for proper information processing in the brain. For exam-
ple, Goldman-Rakic and coworkers demonstrated that
iontophoretic application of bicuculline methiodide, a
competitive antagonist of GABAA  receptors, into the
DLPFC of monkeys performing an oculomotor delayed
response task resulted in the destruction of spatial tuning
of both pyramidal neurons and GABAergic interneurons
[31]. This has been reproduced in computational studies,
which suggests that isodirectional intracortical inhibition
contributes to the stability of the cortical circuit and cross-
directional inhibition contributes to the spatial tuning or
selectivity of working memory to represent [32-34].
Therefore, the alteration of GABAergic neurotransmission
in the cortex would cause dysregulation of the circuit
dynamics, resulting in the impairment of working mem-
ory and other cognitive functions.
A recent neurophysiological study of rats [35] suggests
that chandelier cells, whose spontaneous activity is fairly
low, are reserved to prevent excessive firing of neurons in
the circuit. Chandelier cells are characterized by their syn-
apses on the axonal initial segment of pyramidal neurons
and the reduction of GABAergic neurotransmission in cor-
tical circuits by this type of interneurons might lead to dis-
inhibitory overactivation of the cortex, such as epileptic
activity [36]. Given that the density of the axon terminals
of chandelier cells is reduced in schizophrenia, as sug-
gested by postmortem studies [30,37], one of the conse-
quences of the circuit abnormality in schizophrenia
would be hyperexcitability of the cortex.
Early functional imaging studies reported reduced
responses of the DLPFC or hypofrontality in patients with
schizophrenia [38-41]. Many recent studies suggest over-
activation of the DLPFC during performing working
memory tasks [42-45] or both greater and less activation
of subareas in the DLPFC [46,47]. The DLPFC would be
basically hypodopaminergic, according to the dopamine
(DA) hypothesis of schizophrenia [48]. In this situation,
the GABAergic inhibition in the DLPFC is not strong.
Increasing the DA release in the DLPFC increases glutama-
tergic neurotransmission through N-methyl-D-aspartate
(NMDA) receptors by D1 receptor stimulation. Then, the
activity of the DLPFC increases with the DA release in the
DLPFC. Under hyperdopaminergic conditions, the
GABAergic inhibition becomes so strong that it highly
suppresses noisy signal neurotransmission in the DLPFC
circuit [49]. The DLPFC activity thus shows an inverted-U
shaped profile of the dopaminergic modulation [50,51].
The profile would be sensitive to the strength of the
GABAergic inhibition because the decreasing phase of the
inverted-U shaped curve critically depends on the
GABAergic inhibition in the DLPFC [49-51]. Therefore, if
the GABAergic inhibition in the DLPFC is weakened, as
has been observed in schizophrenia, the activity of the
DLPFC would be significantly different. In this case, neu-
rons in the DLPFC would exhibit hyperexcitation due to
high NMDA currents under hyperdopaminergic condi-
tions [49,52].
Psychostimulants generally increase DA release from
dopaminergic neurons [53]. Psychotic states induced by
psychostimulants are accompanied by the focal activation
of the PFC, and the activity has a positive correlation with
a psychotic symptom [54,55]. Therefore, hyperdopamin-
ergic neurotransmission and hyperactivity would charac-
terize the PFC in acute psychotic states. The conventional
inverted-U shape characteristic of dopaminergic modula-
tion of the PFC activity [50], however, does not predict
this. It rather predicts hypoactivity of the PFC with hyper-
dopaminergic neurotransmission. This unresolved issue
would be an obstacle for advancing our understanding of
the circuit mechanisms of schizophrenia. Recently, the cir-
cuit dynamics of the PFC under dopaminergic modula-
tion has been studied using a computational model of theBMC Neuroscience 2008, 9:41 http://www.biomedcentral.com/1471-2202/9/41
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PFC circuit [34,56-59]. This model predicts how the cir-
cuit dynamics of the PFC varies with D1 receptor activa-
tion. The stability of the PFC circuit varies with the D1
receptor activation when the operating point of the circuit
moves along the inverted-U shaped curve. Using this
model, Tanaka and coworkers extended the range of the
D1 receptor activation to extremely high levels, and
showed that hyperactivation of the PFC can occur under
hyperdopaminergic conditions (they termed this the 'H
mode') [58]. Our study in this article uses essentially the
same model and will explore the roles of GABAergic inhi-
bition in the regulation of such dynamics of the PFC cir-
cuit. The result will show that 'chandelier cell-type
inhibition' controls the H mode activity. GABAergic
interneurons other than chandelier cells do not regulate
this hyperactive mode effectively. Instead, these GABAer-
gic interneurons regulate the conventional inverted-U
shape mode of PFC activity. With these results, we will dis-
cuss the roles of GABAergic inhibition in the regulation
and dysregulation of PFC circuit dynamics. The aim of this
article is to investigate how the GABAergic abnormalities
observed in the patients with schizophrenia alter the PFC
circuit dynamics. Preliminary results have been published
in an abstract form [59].
Results
Mode diagram of the PFC
Equations (4) in Methods describe how the changes in the
neuronal state variables (xp, xc and xn for pyramidal neu-
rons, chandelier cells and other GABAergic interneurons,
respectively) depend on the D1 receptor activation. To
clarify the roles of the chandelier cells, we first see the cir-
cuit dynamics of the PFC without chandelier cells. Figure
1 shows the dependence of the PFC activity on the D1
receptor activation. It is a contour plot of dxp/dt, and the
curves numbered 0 correspond to the equilibrium states
The mode diagram of the PFC with respect to dopaminergic modulation via D1 receptors Figure 1
The mode diagram of the PFC with respect to dopaminergic modulation via D1 receptors. The vertical axis is the 
population activity of the pyramidal neurons in the PFC, and the horizontal axis is the D1 receptor activation level (which is 
denoted by z in the text). Only the curves numbered 0 correspond to the equilibrium state of the PFC circuit. See the text for 
the method of drawing of this diagram.
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of the pyramidal neuron population. The equilibrium
state is obtained mathematically from Equations (4), by
putting dxp/dt = dxc/dt = dxn/dt = 0, as
xp = τp [Wpp(z) fp(xp) - Wnp fn {τn(z)Wpn(z) fp(xp)}] (1)
The above equation does not contain the term for the
chandelier cells (or Wcp = 0) because we first see the circuit
dynamics of the PFC without chandelier cells. The rela-
tionship between xp and z in the above equation gives the
mode diagram, which is identical to the curves for the
equilibrium states in Figure 1. The equilibrium state has
two typical modes of the PFC activity in the different
range of D1 receptor activation, z. One is the inverted-U
mode (1.0 <z < 4.3) and the other is the H mode (z > 6).
There is a gap between these modes (4.3 <z < 6), in which
the activity of the PFC is suppressed. Beyond z = 6, the PFC
has two branches of activity. The upper branch is stable
while the lower branch is unstable, as shown below,
meaning that the dynamics of the PFC circuit is bistable.
Therefore, once the PFC activity becomes higher than the
unstable branch, the activity increases to reach the upper
stable branch, whereas PFC activity that is lower than the
unstable branch decreases to zero.
Analysis
One can see state transitions toward the stable equilib-
rium states by depicting nullclines and fixed points at typ-
ical D1 receptor activation levels. Figure 2 shows the
nullclines for the state variables of the pyramidal neurons
and the GABAergic interneurons other than chandelier
Nullclines of the state variables of the pyramidal neurons and the GABAergic interneurons other than chandelier cells for  three different levels of D1 receptor activation Figure 2
Nullclines of the state variables of the pyramidal neurons and the GABAergic interneurons other than chande-
lier cells for three different levels of D1 receptor activation. A: z = 3.0; B: z = 5.0; C: z = 7.0. The nullcline for the 
pyramidal neurons (dxp/dt = 0) is depicted in blue and the nullcline for the GABAergic interneurons (dxn/dt = 0) is depicted in 
green. The inset (A1) is an enlargement view of A. The circles indicate stable fixed points and the crosses indicate unstable 
fixed points. The arrows show the direction of state transition toward one of the stable fixed points.
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cells, xp and xn. These nullclines are obtained by setting
dxp/dt = dxn/dt = 0 as
These are the equilibrium conditions for the two popula-
tions of neurons. The intersections of these nullclines
indicate, therefore, the equilibrium states of the whole cir-
cuit or the fixed points. The figure shows three different
conditions, mentioned above; i.e., the inverted-U mode
(Figure 2A), the inactive state (Figure 2B), and the H
mode (Figure 2C). The inverted-U mode has a single sta-
ble fixed point, indicated by a circle in Figures 2A and
2A1. The inactive state has no intersection between the
two nullclines, so that only the state xp = xn = 0 is stable. In
the H mode condition, there are two intersections of the
nullclines or fixed points. Among these, the lower fixed
point, indicated by a cross, is unstable, whereas the higher
fixed point, indicated by a circle, is stable. This stable fixed
point characterizes the H mode by hyperactivity of the
PFC neurons.
Roles of GABAergic inhibition
We next investigate the roles of chandelier cells and other
GABAergic interneurons. We see how the changes in the
strength of GABAergic inhibition alter the PFC activity.
The equilibrium condition of the PFC in this case is given
by
xp = τp[Wpp(z)fp(xp) - Wcpfc {τc(z) Wpc(z) fp(xp)} - Wnpfn 
{τn(z) Wpn(z) fp(xp)}] (3)
The results are depicted in Figure 3, which are mode dia-
grams for different levels of GABAergic inhibition. Figure
3A is the same with Figure 1. In Figure 3B, the inhibition
by the chandelier cells is increased, which moves the H
mode away from the inverted-U mode without altering
the inverted-U mode profile. When the inhibition by the
GABAergic interneurons other than chandelier cells
becomes weaker and the chandelier cells are dysfunc-
tional, the inverted-U mode and the H mode are con-
nected (Figure 3C). Stronger inhibition, on the other
hand, shrinks the inverted-U mode but does not affect the
H mode significantly (Figure 3D). This means that the
inverted-U mode, but not the H mode, is sensitive to this
type of inhibition. A further increase in this type of inhi-
bition eliminates the inverted-U mode. In contrast, the H
mode is robust against this type of inhibition; only the
chandelier cells can separate it from the inverted-U mode.
Figure 4 shows the three-dimensional views of the tempo-
ral evolutions of these profiles. The variations of the
parameter values used in the simulation are summarized
in Table 1.
Discussion
Chandelier cells vs other GABAergic interneurons
Our computational studies suggest that the dopaminergic
modulation profile of PFC activity is complex rather than
just an inverted U. A remarkable thing is the possibility of
the existence of the H mode or hyperactive mode of the
PFC with hyperdopaminergic neurotransmission. Both
this mode and the conventional inverted-U mode activity
of the PFC under the dopaminergic modulation would be
regulated by GABAergic neurotransmission. However, the
simulation in this article suggests that these modes have
different sensitivities to different types of GABAergic inhi-
bition. The H mode is sensitive to the GABAergic inhibi-
tion by chandelier cells, whereas the inverted-U mode is
sensitive to the inhibition by GABAergic interneurons
other than chandelier cells. The emergence of the H mode
is, therefore, critically dependent on the strength of the
chandelier cell-type inhibition. Stronger inhibition of this
type puts the H mode away from the inverted-U mode.
This means that, when the GABAergic inhibition by chan-
delier cells is reduced, as suggested in schizophrenia, the
H mode is considered to be closer to the inverted-U mode
than in healthy controls. On the other hand, the profile of
the inverted-U mode is critically dependent on the inhibi-
tion by GABAergic interneurons other than chandelier
cells. If this type of inhibition is stronger, the inverted-U
mode easily disappears. With weaker inhibition of this
type, in contrast, the profile of the inverted-U mode
becomes larger. If both types of inhibition are reduced,
therefore, the inverted-U mode and the H mode would
merge into a single mode. As a result, the state of the PFC
would be able to move to the H mode from the inverted-
U mode.
Transition to the H mode
The transition from the inverted-U mode to the H mode
is illustrated by Figure 5. When the two modes are sepa-
rated (Figure 5A), the inverted-U mode activity decreases
as D1 receptors are activated further. Then, it would be
difficult to cross the gap to reach the H mode. Once they
are connected (Figure 5B), however, it would be much
easier to reach the H mode from the inverted-U mode by,
for example, increasing the D1 receptor activation. The
transition from the inverted-U mode to the H mode
would have important relevance to schizophrenia. First,
the H mode would be associated with psychotic states, as
will be argued below. Second, chandelier cells would pre-
vent the occurrence of psychotic states by suppressing the
H mode activity. Third, weakening of the inhibition by
other GABAergic interneurons increases the probability of
the transition to the H mode or vulnerability to psychosis.
These would explain the reason why schizophrenic brains
are vulnerable to psychosis and are consistent with the
finding of the reduced GABAergic inhibition in the PFC of
patients with schizophrenia.
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Psychosis
Schizophrenia
Functional magnetic resonance imaging (fMRI) studies of
patients with schizophrenia using a verbal fluency task
showed that increasing task demand produced greater
activation of the PFC with higher error rates in psychotic
states compared with remission [60]. A recent fMRI study
suggested an association between reality distortion and
hyperactivity of the medial PFC of patients with schizo-
phrenia or schizoaffective disorders [61]. Besides these, 'it
is postulated that before experiencing psychosis, patients
[with schizophrenia] develop an exaggerated release of
DA, independent of and out of synchrony with the con-
text' [62]. Downregulation of GABAergic neurotransmis-
sion in the PFC has consistently been associated with
schizophrenia [1-5,15]. These support our theory that
psychotic states are induced by the transition to the H
mode due to reduced GABAergic inhibition in the PFC
with hyperdopaminergic neurotransmission.
Substance-induced psychosis
Ketamine and amphetamines induced focal activation of
the PFC in healthy subjects [54,63,64] and in patients
with schizophrenia [65]. In either schizophrenia or drug
addiction, therefore, psychosis is associated with selective
or focal activation of the cortex [54,63-65]. NMDA antag-
onists, such as phencyclidine and ketamine, increase the
extracellular DA concentration in the PFC [66-68]. It has
Mode diagrams Figure 3
Mode diagrams. A: Control. B: With chandelier cells. C: Weaker GABAergic interneurons other than chandelier cells. D: 
Stronger GABAergic interneurons other than chandelier cells. The chandelier cells are dysfunctional in A, C and D.
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been suggested that acute administration of psychostimu-
lants, such as amphetamines and cocaine, increases the
extracellular DA level significantly not only in the subcor-
tical areas but in the PFC [69,70]. A microdialysis study
reported that intraperitoneal administration of 2 mg/kg of
amphetamine to rats induced six-fold increase in the base-
line DA concentration in the PFC [69], which could acti-
vate D1 receptors in the PFC. Recent studies reported that
ketamine, an NMDA antagonist, decreased the expression
of PV and GAD67 in mice [71,72], suggesting reduced
GABAergic inhibition in the PFC. Therefore, the underly-
ing circuit mechanism of substance-induced psychosis
might be the same with schizophrenic psychosis; that is,
the transition to the H mode due to reduced GABAergic
inhibition in the PFC with hyperdopaminergic neuro-
transmission.
Dopamine-mediated mechanisms
Upregulation of D1 receptors
In contrast to acute administration, chronic administra-
tion of psychostimulants lowers the extracellular concen-
tration of DA in the PFC [73,74], which would induce
Three-dimensional representations of DA modulatory landscapes with (B) and without (A, C, and D) chandelier cells Figure 4
Three-dimensional representations of DA modulatory landscapes with (B) and without (A, C, and D) chande-
lier cells. The strength of the inhibition by other GABAergic interneurons are also varied (A: 1.0, B: 1.0, C: 0.95, and D: 1.06). 
Note that the onset of the H mode is very quick (less than 100 ms), whereas the inverted-U mode profiles are very slow to 
evolve. Even at t = 1000 ms, the profiles of the inverted-U mode have not reached the equilibrium states. The profiles at equi-
librium are shown in Figure 3.BMC Neuroscience 2008, 9:41 http://www.biomedcentral.com/1471-2202/9/41
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sensitization of DA receptors. Similarly, the sensitization
of DA receptors would be expected in patients with schiz-
ophrenia. A positron emission tomography (PET) study,
using [11C]NNC 112 as a radiotracer, observed an
increase in the binding potential of D1 receptors in the
PFC of schizophrenia patients [75]. This would reflect a
chronically reduced extracellular DA concentration and
an increase in the density of D1 receptors. Upregulation or
sensitization of D1 receptors might be involved in schizo-
phrenia. An increase in the DA releasability or the respon-
sivity of dopaminergic neurons has also been suggested
[76,77]. These situations would increase the z value in the
model, thereby increasing susceptibility to the H mode.
Stress
Acute stress increases DA turnover in the PFC, which leads
to the impairment of cognitive functions [78,79]. It seems
that metabolic activity of dopaminergic neurons innervat-
ing the PFC is increased selectively in the PFC [80]. The
administration of the stressor FG 7142 also increases DA
turnover in the PFC [81,82]. Chronic stress induced hypo-
dopaminergic states, and, again, impaired cognitive func-
tions [83]. In this case, Bmax or the density of D1 receptors
in rat PFC was significantly increased (from 14.5 with 2.9
SD to 22.3 with 3.5 SD). Interestingly, either the hyper-
dopaminergic state or the hypodopaminergic state with
D1 upregulation could lead to the H mode, according to
the above arguments.
Epilepsy
People with epilepsy are susceptible to schizophrenia-like
psychosis [84-86]. The association between epilepsy and
schizophrenia-like psychosis has long attracted much
attention [87,88], and would be interesting to know the
commonalities between epilepsy and schizophrenia and
the mechanisms underlying both diseases. Epilepsy is
accompanied by excessive excitation of neuronal circuits
in the brain [89,90]. Many studies have suggested selective
alterations in GABAA receptor subtypes in patients with
epilepsy [91,92]. DeFelipe proposed the hypothesis that
the chandelier cell is a key component of cortical circuits
Table 1: A summary of the variations of the parameter values of 
the two different types of GABAergic inhibition used in the 
simulation. 
Chandelier cells Other GABA neurons
A decreased (0.0) unchanged (1.0)
B control (1.0) control (1.0)
C decreased (0.0) decreased (0.95)
D decreased (0.0) increased (1.06)
The figures in the parentheses indicate the relative strength of the 
inhibitory action on the pyramidal neurons in the model PFC circuit.
Mode diagrams and state transition Figure 5
Mode diagrams and state transition. A: When the chandelier cells are dysfunctional but the GABAergic inhibition by the 
other interneurons is normal, the transition from the inverted-U mode to the H mode hardly occurs because of a gap between 
the two modes. The gap becomes wider in the existence of chandelier cells. B: When the chandelier cells are dysfunctional and 
the GABAergic inhibition by the other interneurons is reduced, the two modes are connected, so that the transition to the H 
mode would occur readily.BMC Neuroscience 2008, 9:41 http://www.biomedcentral.com/1471-2202/9/41
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in the establishment of epilepsy [36]. Links to dopamin-
ergic mechanisms have also been suggested [93,94]. Using
whole-cell recording and voltage-sensitive dye imaging
techniques in the rat PFC, Bandyopadhyay et al. [95] dem-
onstrated that bath application of SKF 81297, a selective
D1 receptor agonist, enhanced spatiotemporal spread of
activity in response to weak stimulation and previously
subthreshold stimulation resulted in epileptiform activity
that spread across the whole cortex. This result indicates
that DA, via a D1 receptor-mediated mechanism,
enhances spatiotemporal spread of neuronal activity and
lowers the threshold for epileptiform activity in local cir-
cuits within the PFC. A rat study suggested that the super-
sensitivity of the DA systems, which was developed in the
chronic phase of the kainate-induced temporal lobe epi-
lepsy, was responsible for the genesis of epileptic psycho-
sis [93]. The H mode hypothesis is consistent with all of
these results.
Enhanced cortical inputs
Because of the bistable nature of the H mode, the occur-
rence of the H mode critically depends on the strength of
inputs. They are mediated by corticocortical or thalamo-
cortical afferents to the PFC, and would be modulated by
several ways, including dopaminergic modulation. It has
also been suggested that DA has a sensorimotor gating
function in PFC and subcortical circuits [96-99]. In fact,
many studies have reported deficits in the sensorimotor
gating function in patients with schizophrenia (for
reviews: [98,100,101]) and, interestingly, also in amphet-
amine-sensitized animals [102]. When a dysregulated or
unfiltered input is given to the PFC, the PFC would
respond to it with hyperactivity. Recent neurophysiologi-
cal study in monkey reported an enhancement of the
response-period activity of DLPFC neurons, but no effect
on delay-period activity, by the stimulation of the D2
receptors in the DLPFC [103]. This may suggest that D2
receptors are involved in gating afferent input to the
DLPFC circuit for working memory and other cognitive
functions. Moreover, if D2 receptors are supersensitive
[104,105], the H mode would more readily emerge
because hyperactivation of D2 receptors could contribute
to the enhancement of the input to the PFC.
Conclusion
We have investigated how GABAergic inhibition by chan-
delier cells and other GABAergic interneurons contribute
to the regulation of neuronal activity in the PFC circuit.
The results show that the roles of the two different types
of GABAergic inhibition on PFC circuit dynamics are
markedly different. The inhibition by GABAergic
interneurons other than chandelier cells effectively regu-
lates the PFC activity with rather low or modest levels of
dopaminergic neurotransmission, which has an inverted-
U shaped profile of dopaminergic modulation and is
associated with normal cognitive functions. In contrast,
the chandelier cell-type inhibition regulates the PFC activ-
ity with hyperdopaminergic neurotransmission. There-
fore, dysfunction of chandelier cells in the PFC would
produce the H mode, a "psychotic" hyperactive state with
hyperdopaminergic neurotransmission. Reduction of the
inhibition by other GABAergic interneurons would make
the transition to the H mode more readily occur, thereby
increasing vulnerability to psychosis.
Methods
Prefrontal Cortical Circuit Model
Our model of the PFC contains pyramidal neurons and
GABAergic interneurons (Figure 6). The pyramidal neu-
rons have recurrent connections or self-innervations. The
two populations of neurons are connected reciprocally.
All of the neurons in the model are assumed to be under
dopaminergic modulation via D1 receptors; D1 receptor
activation changes the synaptic strengths from pyramidal
neurons to both pyramidal neurons and interneurons as
well as the time constant for the interneurons [34,106].
The dopaminergic modulation via D1 receptors in this
model is consistent with that of Durstewitz et al. [107] but
is a reduced one that is suitable for the present analysis
with the firing rate model.
The pyramidal neurons receive a transient external input,
which triggers the dynamics of the circuit. Our model
A schematic diagram of the model Figure 6
A schematic diagram of the model. The PFC contains 
pyramidal neurons and GABAergic interneurons (chandelier 
cells (C) and others (N)), which are connected reciprocally 
and have also self-innervations. All populations of neurons 
are under dopaminergic modulation via D1 receptors. The 
transient input to the pyramidal neurons triggers the dynam-
ics of the circuit.
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describes the activity of each population of neurons
(either pyramidal neurons or GABAergic interneurons) by
a single state variable, which therefore describes the pop-
ulation activity. The state equations for the population
activities are given by
where xp, xc and xn are the state variables for the pyramidal
neuron population, the chandelier cell population, and
the population of the GABAergic interneurons other than
chandelier cells, p, c and n denote the pyramidal neurons,
the chandelier cells, and the GABAergic interneurons
other than chandelier cells, respectively, τp, τc and τn are
the time constants of these neurons, Wij (i, j = p, c, n) is the
synaptic efficacy from population i to j, and Icue is the tran-
sient external input to the pyramidal neuron population.
The parameters that depend on z are subject to dopamin-
ergic modulation, where z is the D1 receptor activation
(see below). The activation function is assumed to be
common to the populations of pyramidal neurons and
GABAergic interneurons other than chandelier cells:
where fmax is the maximum firing rate. The activation func-
tion for the chandelier cell population will be given
below. The simulation used the values of the parameters
in the above equations as: fmax = 100 sp/s, τp = 20.0, τc (0)
= τn (0) = 5.0, Wpp (0) = 0.00055, Wpc (0) = Wpn (0) =
0.00035, Wcp = 0.0002, and Wnp = 0.0005.
GABAergic Interneurons
Spontaneous activity of chandelier cells is fairly low but
they fire action potentials at frequencies higher than other
GABAergic interneurons when the overall cortical excita-
tion increases, suggesting that their role is to suppress
excessive excitation via their powerful inhibitory synapses
on pyramidal neurons [35,108]. With their unique syn-
apses on the axonal initial segment, chandelier cells
would increase their inhibitory effects when the GABA
release from chandelier cell axon terminals becomes coin-
cident with spike generation of the postsynaptic pyrami-
dal neurons. This would require highly repetitive inputs
from pyramidal neurons so that chandelier cells can fire at
a high rate. Therefore, the inhibitory effect by the chande-
lier cell would increase sharply when the firing rate
exceeds a certain threshold. We describe this characteristic
of inhibitory effect by chandelier cells simply with an acti-
vation function
fc (x) = fmax tanh(x - x0)( 6 )
where x0 = 0.8 is the threshold above which the inhibition
by the chandelier cell becomes effective. Figure 7 shows
the profiles of the activation functions for the populations
of the chandelier cells and other GABAergic interneurons.
The difference in physiological properties between these
populations of neurons exists only in the thresholds in the
activation functions. For a network model consisting of
different types of interneurons with Hodgkin-Huxley
models, refer to [109], which studied differential contri-
butions to working memory representation in the DLPFC.
It would be interesting to see how the subtypes of
interneurons affect the profile of PFC activity under
dopaminergic modulation.
Dopaminergic Modulation via D1 Receptors
The activation of D1 receptors affects the channel con-
ductances, such as the conductances of ?-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)
and NMDA receptor-channels (for reviews: [110,111]).
These change the efficacy of glutamatergic signal neuro-
transmission (Wpp, Wpc and Wpn in this model). The excit-
ability of the PFC inhibitory interneurons increases with
D1 receptor activation by decreasing the potassium-chan-
nel conductance [112]. This leads to a model in which the
time constants of the interneurons, τc and τn, are assumed
to decrease with D1 receptor activation [34,106]. Taken
together, our model describes these effects by
dxp
dt
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p
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The profiles of the activation functions of the chandelier cells  (C) and the other GABAergic interneurons (N) in the model Figure 7
The profiles of the activation functions of the chande-
lier cells (C) and the other GABAergic interneurons 
(N) in the model.
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where a, b and c are constants (a = 0.2, b = 0.4, c = 0.3).
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